Multi‐centre Phase II Study of Low Dose Intravesical Epirubicin in the Treatment of Superficial Bladder Cancer
- 1 June 1991
- journal article
- clinical trial
- Published by Wiley in British Journal of Urology
- Vol. 67 (6) , 600-602
- https://doi.org/10.1111/j.1464-410x.1991.tb15223.x
Abstract
Summary— Forty patients with multiple recurrent superficial bladder tumours received an 8‐week course of weekly instillations of 4' epirubicin 30 mg in 50 ml saline. The overall response rate was 58% and side effects were minimal.Keywords
This publication has 6 references indexed in Scilit:
- A Multi-Centre Phase Two Study of Intravesical Epirubicin in the Treatment of Superficial Bladder TumourEuropean Urology, 1990
- Adverse Reactions to the Intravesical Administration of Doxorubicin Hydrochloride: Report of 6 CasesJournal of Urology, 1986
- Randomized clinical trial on chemoprophylaxis of recurrence in cases of superficial bladder cancerCancer Chemotherapy and Pharmacology, 1983
- Intravesical Adriamycin chemotherapy in bladder cancerCancer Chemotherapy and Pharmacology, 1983
- Toxic and Therapeutic Activity of 4'-Epi-DoxorubicinTumori Journal, 1982